This article is from the source 'bbc' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at http://www.bbc.co.uk/news/business-23352844

The article has changed 5 times. There is an RSS feed of changes available.

Version 0 Version 1
GlaxoSmithKline finance head banned from leaving China GlaxoSmithKline finance head banned from leaving China
(35 minutes later)
Chinese authorities looking into alleged bribery by GlaxoSmithKline have banned the UK drugmaker's British head of finance from leaving China.Chinese authorities looking into alleged bribery by GlaxoSmithKline have banned the UK drugmaker's British head of finance from leaving China.
The travel ban was imposed on Steve Nechelput at the end of June, said a company spokesperson.The travel ban was imposed on Steve Nechelput at the end of June, said a company spokesperson.
On Monday, police in China said GSK had transferred 3bn yuan ($489m; £321m) to travel agencies and consultancies to facilitate bribes to doctors.On Monday, police in China said GSK had transferred 3bn yuan ($489m; £321m) to travel agencies and consultancies to facilitate bribes to doctors.
GSk has said it is deeply "concerned and disappointed" by the allegations.GSk has said it is deeply "concerned and disappointed" by the allegations.
Chinese authorities have taken into custody four Chinese executives at GSK in connection with the allegations. The company said Mr Nechelput had not been questioned or detained by police. The company said Mr Nechelput had not been questioned or detained by police.
GSK's general manager for China, Mark Reilly, had previously left the country for Britain. Chinese authorities have taken into custody four Chinese executives at GSK in connection with the allegations. That includes vice-president and operations manager Liang Hong, who appeared on state television and said he had funnelled money through travel agencies for arranged conferences, some of which were never held.
GSK's general manager for China, Mark Reilly, is said to have left the country for Britain last month.
Chinese authorities have accused GSK of using travel agencies to bribe government officials, doctors and hospitals in order to boost sales and prices of their drugs.Chinese authorities have accused GSK of using travel agencies to bribe government officials, doctors and hospitals in order to boost sales and prices of their drugs.
On Monday, Gao Feng, head of the economic crimes investigation, said similar transfers had been made by other pharmaceutical multinationals. He did not name any other foreign companies.On Monday, Gao Feng, head of the economic crimes investigation, said similar transfers had been made by other pharmaceutical multinationals. He did not name any other foreign companies.
GSK has said it is taking immediate action, including terminating links with the travel agencies that the Chinese authorities have identified, and conducting a review of its transactions related to the travel agencies.